vs

Side-by-side financial comparison of CME Group (CME) and JBT Marel Corp (JBTM). Click either name above to swap in a different company.

CME Group is the larger business by last-quarter revenue ($1.9B vs $1.0B, roughly 1.9× JBT Marel Corp). JBT Marel Corp runs the higher net margin — 5.3% vs 0.1%, a 5.2% gap on every dollar of revenue. On growth, JBT Marel Corp posted the faster year-over-year revenue change (115.6% vs 14.5%). Over the past eight quarters, JBT Marel Corp's revenue compounded faster (60.3% CAGR vs 10.8%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

JBT Marel Corporation, formerly known as JBT Corporation, or John Bean Technologies Corporation, is a food processing machinery and automated vehicle company. The company was incorporated in 2008 when FMC Technologies divested its non-energy businesses. The company is based in Chicago, Illinois and traces its history back to a company founded in 1884 by John Bean, an orchardist in Los Gatos, California.

CME vs JBTM — Head-to-Head

Bigger by revenue
CME
CME
1.9× larger
CME
$1.9B
$1.0B
JBTM
Growing faster (revenue YoY)
JBTM
JBTM
+101.1% gap
JBTM
115.6%
14.5%
CME
Higher net margin
JBTM
JBTM
5.2% more per $
JBTM
5.3%
0.1%
CME
Faster 2-yr revenue CAGR
JBTM
JBTM
Annualised
JBTM
60.3%
10.8%
CME

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CME
CME
JBTM
JBTM
Revenue
$1.9B
$1.0B
Net Profit
$1.2M
$53.1M
Gross Margin
34.5%
Operating Margin
0.1%
7.2%
Net Margin
0.1%
5.3%
Revenue YoY
14.5%
115.6%
Net Profit YoY
20.7%
858.6%
EPS (diluted)
$1.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
JBTM
JBTM
Q1 26
$1.9B
Q4 25
$1.6B
$1.0B
Q3 25
$1.5B
$1.0B
Q2 25
$1.7B
$934.8M
Q1 25
$1.6B
$854.1M
Q4 24
$1.5B
$467.6M
Q3 24
$1.6B
$453.8M
Q2 24
$1.5B
$402.3M
Net Profit
CME
CME
JBTM
JBTM
Q1 26
$1.2M
Q4 25
$1.2B
$53.1M
Q3 25
$908.0M
$66.0M
Q2 25
$1.0B
$3.4M
Q1 25
$956.2M
$-173.0M
Q4 24
$874.6M
$-7.0M
Q3 24
$912.8M
$38.9M
Q2 24
$883.2M
$30.7M
Gross Margin
CME
CME
JBTM
JBTM
Q1 26
Q4 25
34.5%
Q3 25
35.9%
Q2 25
35.8%
Q1 25
34.2%
Q4 24
38.4%
Q3 24
36.1%
Q2 24
35.6%
Operating Margin
CME
CME
JBTM
JBTM
Q1 26
0.1%
Q4 25
61.8%
7.2%
Q3 25
63.3%
10.2%
Q2 25
66.7%
5.2%
Q1 25
67.5%
-3.9%
Q4 24
62.1%
3.4%
Q3 24
64.6%
10.3%
Q2 24
65.3%
6.7%
Net Margin
CME
CME
JBTM
JBTM
Q1 26
0.1%
Q4 25
71.7%
5.3%
Q3 25
59.1%
6.6%
Q2 25
60.6%
0.4%
Q1 25
58.2%
-20.3%
Q4 24
57.3%
-1.5%
Q3 24
57.6%
8.6%
Q2 24
57.6%
7.6%
EPS (diluted)
CME
CME
JBTM
JBTM
Q1 26
Q4 25
$3.24
$1.04
Q3 25
$2.49
$1.26
Q2 25
$2.81
$0.07
Q1 25
$2.62
$-3.35
Q4 24
$2.40
$-0.22
Q3 24
$2.50
$1.21
Q2 24
$2.42
$0.95

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
JBTM
JBTM
Cash + ST InvestmentsLiquidity on hand
$2.4B
$167.9M
Total DebtLower is stronger
$3.4B
$1.5B
Stockholders' EquityBook value
$4.5B
Total Assets
$202.0B
$8.2B
Debt / EquityLower = less leverage
0.33×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
JBTM
JBTM
Q1 26
$2.4B
Q4 25
$4.5B
$167.9M
Q3 25
$2.6B
Q2 25
$2.1B
Q1 25
$1.5B
Q4 24
$3.0B
$1.2B
Q3 24
$2.4B
Q2 24
$1.9B
Total Debt
CME
CME
JBTM
JBTM
Q1 26
$3.4B
Q4 25
$1.5B
Q3 25
$1.5B
Q2 25
$1.5B
Q1 25
$2.0B
Q4 24
$1.3B
Q3 24
$648.3M
Q2 24
$647.7M
Stockholders' Equity
CME
CME
JBTM
JBTM
Q1 26
Q4 25
$28.7B
$4.5B
Q3 25
$28.2B
$4.4B
Q2 25
$27.7B
$4.4B
Q1 25
$27.0B
$4.1B
Q4 24
$26.5B
$1.5B
Q3 24
$28.2B
$1.6B
Q2 24
$27.6B
$1.5B
Total Assets
CME
CME
JBTM
JBTM
Q1 26
$202.0B
Q4 25
$198.4B
$8.2B
Q3 25
$187.1B
$8.2B
Q2 25
$179.9B
$8.3B
Q1 25
$157.8B
$8.0B
Q4 24
$137.4B
$3.4B
Q3 24
$137.8B
$2.8B
Q2 24
$123.4B
$2.7B
Debt / Equity
CME
CME
JBTM
JBTM
Q1 26
Q4 25
0.33×
Q3 25
0.34×
Q2 25
0.35×
Q1 25
0.48×
Q4 24
0.81×
Q3 24
0.41×
Q2 24
0.43×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CME
CME
JBTM
JBTM
Operating Cash FlowLast quarter
$117.4M
Free Cash FlowOCF − Capex
$83.5M
FCF MarginFCF / Revenue
8.3%
Capex IntensityCapex / Revenue
3.4%
Cash ConversionOCF / Net Profit
2.21×
TTM Free Cash FlowTrailing 4 quarters
$238.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CME
CME
JBTM
JBTM
Q1 26
Q4 25
$1.1B
$117.4M
Q3 25
$968.1M
$87.7M
Q2 25
$1.1B
$102.2M
Q1 25
$1.1B
$34.4M
Q4 24
$1.0B
$128.7M
Q3 24
$1.0B
$71.9M
Q2 24
$776.9M
$21.6M
Free Cash Flow
CME
CME
JBTM
JBTM
Q1 26
Q4 25
$1.1B
$83.5M
Q3 25
$949.7M
$56.5M
Q2 25
$1.0B
$83.7M
Q1 25
$1.1B
$14.4M
Q4 24
$991.7M
$118.7M
Q3 24
$973.2M
$65.0M
Q2 24
$758.7M
$11.1M
FCF Margin
CME
CME
JBTM
JBTM
Q1 26
Q4 25
66.8%
8.3%
Q3 25
61.8%
5.6%
Q2 25
61.5%
9.0%
Q1 25
67.1%
1.7%
Q4 24
65.0%
25.4%
Q3 24
61.4%
14.3%
Q2 24
49.5%
2.8%
Capex Intensity
CME
CME
JBTM
JBTM
Q1 26
Q4 25
2.0%
3.4%
Q3 25
1.2%
3.1%
Q2 25
1.1%
2.0%
Q1 25
0.9%
2.3%
Q4 24
1.7%
2.1%
Q3 24
1.9%
1.5%
Q2 24
1.2%
2.6%
Cash Conversion
CME
CME
JBTM
JBTM
Q1 26
Q4 25
0.96×
2.21×
Q3 25
1.07×
1.33×
Q2 25
1.03×
30.06×
Q1 25
1.17×
Q4 24
1.16×
Q3 24
1.10×
1.85×
Q2 24
0.88×
0.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons